Treatment with the cancer drugs decitabine and doxorubicin induces human skin keratinocytes to express Oct4 and the OCT4 regulator mir-145

Journal of Dermatology

Volumn 39, Issue 7, 2012, Pages 617-624

  Chinnathambi, Sathivel ^a   Wiechert, Susan ^a   Tomanek Chalkley, Ann ^a   Winter, Michael C ^a   Bickenbach, Jackie R ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Decitabine (5 aza 2 deoxycytidine); DNA demethylation; Doxorubicin; Keratinocytes; mir 145; Oct4

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DOXORUBICIN; MICRORNA 145; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; CELL PROLIFERATION; DNA METHYLATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PROTEIN EXPRESSION; SOMATIC CELL;

ANTINEOPLASTIC AGENTS; AZACITIDINE; CELL PROLIFERATION; CELLS, CULTURED; DNA METHYLATION; DOXORUBICIN; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-3; SKIN;

EID: 84862251333     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01553.x     Document Type: Article

References (31)

1. Okita K, Hong H, Takahashi K, Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010; 5: 418-428.
2. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27: 543-549.
3. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 2009; 6: 363-369.
4. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009; 15: 59-68.
5. Racila D, Winter M, Said M et al. Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway. Gene Ther 2011 18, 294-303.
6. Hattori N, Nishino K, Ko YG, Ohgane J, Tanaka S, Shiota K. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J Biol Chem 2004; 279: 17063-17069.
7. Dhawan S, Georgia S, Tschen SI, Fan G, Bhushan A. Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx. Dev Cell 2011; 20: 419-429.
8. Christman JK. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 2002; 21: 5483-5495.
9. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009; 137: 647-658.
10. Wu Y, Liu S, Xin H et al. Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells. Cancer 2011; 117: 3989-3998.
11. Yin R, Zhang S, Wu Y et al. microRNA-145 suppresses lung adenocarcinoma- initiating cell proliferation by targeting OCT4. Oncol Rep 2011; 25: 1747-1754.
12. Card DA, Hebbar PB, Li L et al. Oct4 ? Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426-6438.
13. Suh MR, Lee Y, Kim JY et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004; 270: 488-498.
14. Sachdeva M, Zhu S, Wu F et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009; 106: 3207-3212.
15. Rogstad DK, Herring JL, Theruvathu JA et al. Chemical decomposition of 5-aza-2′-deoxycytidine (Decitabine): kinetic analyses and identification of products by NMR, HPLC, and mass spectrometry. Chem Res Toxicol 2009; 22: 1194-1204.
16. Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95-101.
17. Qian Q, Qian H, Zhang X et al. 5-azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev 2011; 21: 67-75.
18. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 91: 501-508.
19. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008; 40: 1478-1483.
20. Wang Y, Blelloch R. Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res 2009; 69: 4093-4096.
21. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005; 435: 974-978.
22. Fluckiger AC, Marcy G, Marchand M et al. Cell cycle features of primate embryonic stem cells. Stem Cells 2006; 24: 547-556.
23. Lin SL, Chang DC, Chang-Lin S et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008; 14: 2115-2124.
24. George RE, Lahti JM, Adamson PC et al. Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer 2010; 55: 629-638.
25. Tan HH, Porter AG. DNA methyltransferase I is a mediator of doxorubicin-induced genotoxicity in human cancer cells. Biochem Biophys Res Commun 2009; 382: 462-467.
26. Katona TM, Billings SD, Montironi R, Lopez-Beltran A, Cheng L. Expression of OCT4 transcription factor in cutaneous neoplasia. Appl Immunohistochem Mol Morphol 2007; 15: 359-362.
27. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005; 26: 495-502.
28. Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 621-628.
29. Alcazar O, Achberger S, Aldrich W et al. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int J Cancer 2011; doi: 10.1002/ijc.26320.
30. Weber J, Salgaller M, Samid D et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 1994; 54: 1766-1771.
31. Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine. Mol Pharmacol 2004; 65: 18-27.